Site Map

Home

• FAQs & Contact
• Terms and Conditions of Website Use
• Handling of Personal Information
• Social Media Policy
• Recommended Environment
• Web Accessibility
• Cookie Policy
• Chugai Group Privacy Statement
• Clinical Trials Information

About Chugai

• Understanding Chugai: Our Company and History
  • What kind of company is Chugai?
  • History of Chugai Pharmaceutical
• Message from the CEO
• Our Vision
  • Mission Statement and Chugai Group Code of Conduct
  • Slogan
• Our Strategy
  • Basic Management Policy
  • Chugai’s Value Creation Model
  • Strategic Alliance with Roche
  • Growth strategy “TOP I 2030”
• Company Outline
  • Company Profile
  • Business Processes
  • Directors & Officers
  • Organization
  • Company Brochure & Reports
  • Chugai Group
• Supplier
  • Procurement system “myBuy” : How to access myBuy and participate in RFx events
  • Contact details
• Videos & Advertisements
• Press Room

Innovation

• R&D
  • Features of Drug Discovery Approaches
  • Platforms & Technologies
  • Chugai R&D Principles
  • Open Innovation
  • R&D Bases
  • Clinical Development
  • Production Technology
  • Intellectual Property
  • Other Guidelines
  • R&D Process
  • Chugai R&D Glossary
• Digital Transformation
  • CHUGAI DIGITAL VISION 2030
  • Build a Company-wide Digital Infrastructure & Enhance Productivity Across All Value Chains
  • AI-leveraging drug discovery
  • Digital biomarkers (dBM) initiatives
  • Utilization of real-world data (RWD)
• Partnering
  • Technology
  • Oncology
  • Neuroscience
  • Ophthalmology
  • Immunology/Respiratory
  • Cardiovascular/Metabolism
  • Other Disease Areas
  • Antibody Engineering Technology Licensing

Sustainability

• Chugai’s Sustainability
  • Top Management Commitment
  • Value Shared with Stakeholders
  • Chugai’s Material Issues
  • Sustainability Promotion System
• Advanced and sustainable patient-centric healthcare
  • Drug Safety Core Themes and Initiatives
  • Anti-Counterfeit Initiatives
  • Increasing Product Reliability
• Global Environment
  • Environmental, Health and Safety Policy/Basic Approach
  • EHS Promotional Activities System
  • Goals and Initiatives
  • Disclosures based on the TCFD recommendations
  • Climate Change Countermeasures
  • Use of Renewable/Recycled Resources
  • Protection of Biodiversity
  • Education and Training
  • Environmental Investment
• Human Rights
  • Chugai Group Human Rights Initiatives
  • Education regarding respect for human rights
  • Our Approach to Clinical Trials
• Talent Management
  • Initiatives to Promote the Success of Diverse Employees
  • DE&I Promotion System
  • People & Culture Report
  • Personnel Systems
  • Message from Management on DE&I
  • DE&I Vision and Performance
  • Facilitating Work/Life Balance
• Health and Productivity Management
  • Environmental, Health and Safety Policy/Basic Approach
  • EHS Promotional Activities System
  • Goals and Initiatives
  • Chugai Group Declaration on Health
  • Health and Productivity Management Map
  • Countermeasures against Smoking
  • Health and Safety Activities
  • Preventing occupational injuries
  • Education and Training
• Social Contribution
  • Five Priority Areas
  • Disaster support activities
  • Chugai Supports Para-Sports
• Global Health
  • Chugai’s Basic Approach to Global Health
  • Priorities in Addressing Global Health
  • Projects We Have Joined
• Governance
  • Risk Management
  • IT Security and Information Management
  • Chugai Pharmaceutical Risk Appetite Statement
• Ethics and Compliance
  • Initiatives for Compliance
  • Healthcare Compliance based on the Chugai Code of Practice
  • Biotechnology Policies
  • Chugai's Transparency Guidelines
  • Policy on Research Using Human Stem Cells
  • Policy for Research by Animals
• Supply Chain Management
  • Measure, Purchasing Policy and Rules for Purchasing Ethics
  • Creation of a System for Comprehensive Assessment of Suppliers
  • Response in Emergencies
• Activity Reports
• Data
  • Sustainability Policy and Data 2023
  • DE&I Data
• Policy/Guidelines
• External Evaluations

Stories

Investor Relations

• Management Policy
  • Message from the CEO
  • Mission Statement and Chugai Group Code of Conduct
  • Growth strategy “TOP I 2030”
  • Business Risk
  • Disclosure Policy
• Financial Results
  • Latest Results
  • Financial Results and Other Indicators
  • Revenue by Product
  • Movements of assets and liabilities
  • Movements of Free Cash Flows
  • Performance Indicators
• Shareholder Information
  • Notices
  • Shareholder Meetings
  • Information on Shares
  • Shareholder Returns
  • Share Ownership
  • Analyst Coverage
  • Bonds & Ratings
  • Share Price
  • Articles of Incorporation
• Reports & Downloads
  • Quarterly Reports / Finance Reports
  • Presentation Materials
  • Downloads
  • Annual Reports
  • ESG at Chugai
  • Events & Presentations
• Corporate Governance
  • Basic Approach
  • Introduction of Outside Perspectives
  • Auditing System and Internal Control System
  • Officer Remuneration
  • Policy regarding the strategic shareholdings
  • Communication with Stakeholders
  • Corporate Governance Report and Related Materials
  • Messages from the Chairs of the Committees
• See how Chugai compares to other companies
• Products / Development Pipeline / Technology
  • Main Products
  • Development Pipeline
  • Applied Technology
• Contacts & Information
  • E-mail Alerts
  • IR Contact
  • Disclaimer
  • FAQs

Recruitment

• Chugai Recruiting Site
  • Message from Top Management
  • Innovations of the Chugai Pharmaceutical
  • Chugai Pharmaceutical in Numbers
  • Employee Interviews
  • Panel Discussions with Employees
  • Graduate Recruitment
  • Mid-carrier Recruitment (Open in a new window)
  • Recruitment of the Disabled
  • Recruitment Q&A

News Room

• News
• Media Conference
• Press Room